InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,633.91
(
1.02%
)
US TECH 100
20,111.20
(
-0.04%
)
Dow Jones
39,721.36
(
1.09%
)
Brent Oil
84.98
(
-0.08%
)
Bitcoin
58,186.53
(
0.74%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1060
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 96

Wednesday, 04/11/2018 1:49:50 AM

Wednesday, April 11, 2018 1:49:50 AM

Post# of 438
RYTM is testing lead compound in 6 rare indications. Total addressable market in U.S. & EU = 15K patients

4/2/18 in-licensed appetite control from Takeda for $5mn upfront

12/31/17 had $148mn cash with a runway into H2/2019.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up